United States · FDA National Drug Code directory
Buspirone hydrochloride
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 50268-135_4c3657a8-f6bd-b2a4-e063-6394a90a741d
- Product NDC
- 50268-135
- Form
- TABLET
- Composition / generic term
- Buspirone hydrochloride
- Labeler
- AvPAK
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20201021
- Source listing expiry
- 20271231
Source-listed ingredients
- BUSPIRONE HYDROCHLORIDE — 15 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 50 BLISTER PACK in 1 BOX (50268-135-15) / 1 TABLET in 1 BLISTER PACK (50268-135-11) · 50268-135-15
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →